Agios PharmaceuticalsAGIO
那斯達克 · USD
35.00
-2.22
(-5.96%)
收盤 08/02 03:59 (UTC+8)
盤後
0
0
(0%)
08/02 03:59 (UTC+8)
Agios PharmaceuticalsAGIO
35.00
-2.22
(-5.96%)
財務數據
損益表
- 0.06
- 0.07
- 0.07
- 0.07
- 0.08
- 0.09
- 0.09
- 0.11
- 0.09
- 0.12
- 30.14
- 19.66
- 10.24
- -4.00
- 15.29
- 5.20
- 4.05
- 19.70
- -18.68
- 42.73
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | |
營業收入淨額 | 12,455 | 8,726 | 10,730 | 8,964 | 8,615 | 8,189 | 7,103 | 7,399 | 6,712 | 5,609 |
營業成本 | - | 1,085 | 1,260 | 783 | 1,495 | 627 | 586 | 633 | 1,108 | 554 |
營業毛利 | - | 7,641 | 9,470 | 8,181 | 7,120 | 7,562 | 6,517 | 6,766 | 5,604 | 5,055 |
營業費用 | - | 114,270 | - | - | - | - | 112,794 | 107,663 | 99,304 | 95,668 |
研發費用 | - | 72,743 | 82,810 | 72,455 | 77,401 | 68,620 | 77,489 | 81,841 | 68,895 | 67,301 |
推銷及管理費用 | - | 41,527 | 51,697 | 38,537 | 35,536 | 31,014 | 35,305 | 25,822 | 30,409 | 28,367 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -127,056 | -106,629 | -125,037 | -102,811 | -105,817 | -92,072 | -106,277 | -100,897 | -93,700 | -90,613 |
其他收入及費用 | - | 17,340 | 19,638 | 1,103,846 | 9,699 | 10,523 | 10,337 | 9,573 | 9,894 | 9,595 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | - | -89,289 | -105,399 | 1,001,035 | -96,118 | -81,549 | -95,940 | -91,324 | -83,806 | -81,018 |
所得稅 | - | - | -8,876 | 53,120 | - | - | - | - | - | - |
稅後純益 | -112,020 | -89,289 | -96,523 | 947,915 | -96,118 | -81,549 | -95,940 | -91,324 | -83,806 | -81,018 |
基本每股稅後盈餘(元) | -1.93 | -1.55 | -1.65 | 16.65 | -1.69 | -1.45 | - | -1.64 | -1.51 | -1.47 |
稀釋每股稅後盈餘(元) | -1.93 | -1.55 | -1.74 | 16.52 | -1.69 | -1.45 | -1.72 | -1.64 | -1.50 | -1.47 |
基本平均股數(千股) | 57932.00 | 57459.00 | 57105.00 | 56939.00 | 56802.00 | 56383.00 | - | 55803.00 | 55604.00 | 55265.00 |
稀釋平均股數(千股) | 57932.00 | 57459.00 | 59940.00 | 58432.00 | 56802.00 | 56383.00 | - | 55803.00 | 55604.00 | 55265.00 |
還原基本每股稅後盈餘(元) | -1.93 | -1.55 | -1.65 | 16.65 | -1.69 | -1.45 | - | -1.64 | -1.51 | -1.47 |
還原稀釋每股稅後盈餘(元) | -1.93 | -1.55 | -1.74 | 16.52 | -1.69 | -1.45 | -1.72 | -1.64 | -1.50 | -1.47 |
還原基本平均股數(千股) | 57,932 | 57,459 | 57,105 | 56,939 | 56,802 | 56,383 | - | 55,803 | 55,604 | 55,265 |
還原稀釋平均股數(千股) | 57,932 | 57,459 | 59,940 | 58,432 | 56,802 | 56,383 | - | 55,803 | 55,604 | 55,265 |
EBITDA(千元) | -112,020 | -89,359 | -109,648 | 998,646 | -97,134 | -82,728 | -94,930 | -88,621 | -84,961 | -82,004 |